Ovarian Reserve and Assisted Reproductive Technique Outcomes After Laparoscopic Proximal Tubal Occlusion or Salpingectomy in Women with Hydrosalpinx Undergoing in Vitro Fertilization: A Randomized Controlled Trial

被引:20
|
作者
Vignarajan, Chithira Pulimoottil [1 ]
Malhotra, Neena [1 ]
Singh, Neeta [1 ]
机构
[1] All India Inst Med Sci, ART Ctr, Dept Obstet & Gynaecol, New Delhi, India
关键词
Hydrosalpinx; Proximal tubal occlusion; Salpingectomy; EMBRYO TRANSFER; HORMONE-LEVELS; IMPLANTATION; DAMAGE;
D O I
10.1016/j.jmig.2018.10.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective: To evaluate the outcomes of assisted reproductive technology (ART) after proximal tubal occlusion (PTO) or salpingectomy in patients with hydrosalpinx undergoing in vitro fertilization-embryo transfer (IVF-ET). Design: Randomized controlled trial (Canadian Task Force classification I). Setting: All India Institute of Medical Sciences, New Delhi, India. Patients: A total of 165 patients were randomized and subsequently allocated to a PTO group (n = 83) or a salpingectomy group (n = 82). Interventions: PTO and salpingectomy. Measurements and Main Results: Following surgery, compared with the PTO group, the salpingectomy group showed significant decreases in the ovarian reserve parameters serum anti-Mullerian hormone (AMH; 3.7 ng/mL vs 2.6 ng/mL; p < .001) and antral follicle count (AFC; 10.6 vs 8.6; p < .001). The salpingectomy group also required a significantly higher dose of gonadotropins (3901 vs 3260; p < .001) and more days of stimulation (11.3 vs 10.2; p < .001) compared with the PTO group. The salpingectomy group had a significantly lower fertilization rate (0.74 vs 0.83; p < .001) and a lower number of grade 1 embryos (4.1 vs 5.6; p = .02); however, there was no significant difference between the 2 groups with respect to rates of implantation (22.8% vs 23.7%; p = .87), clinical pregnancy (26.3% vs 33.7%, p = .25), live birth (27.5% vs 32.5%; p = .42), and miscarriage (4.7% vs 3.5%; p = .90) Conclusions: PTO is a superior to salpingectomy for the surgical management of patients with hydrosalpinx undergoing IVF-ET in terms of ovarian reserve. However, the 2 surgical techniques are associated with comparable pregnancy rates. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1070 / 1075
页数:6
相关论文
共 42 条
  • [31] Reproductive outcomes after laparoscopic surgery in infertile women affected by ovarian endometriomas, with or without in vitro fertilisation: results from the SAFE (surgery and ART for endometriomas) trial
    Ban Frangez, Helena
    Vrtacnik Bokal, Eda
    Stimpfel, Martin
    Divjak Budihna, Teja
    Gulino, Ferdinando Antonio
    Garzon, Simone
    Ghezzi, Fabio
    Alkatout, Ibrahim
    Gitas, Georgios
    Lagana, Antonio Simone
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 1293 - 1300
  • [32] Endometrial injury performed during the cycle preceding ovarian stimulation increases the biochemical pregnancy rate in unselected infertile women undergoing in vitro fertilization: a randomized placebo controlled trial
    Zhao, S. Y.
    Liu, Y.
    Yu, L. P.
    Chao, H.
    Liu, M. H.
    Zhao, Y. Y.
    HUMAN REPRODUCTION, 2015, 30 : 279 - 279
  • [33] Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial
    Liu, Yali
    Chen, Qiuju
    Yu, Sha
    Wang, Yun
    He, Wen
    Chang, Hannah Ya-Ning
    Wang, Bian
    Gao, Hongyuan
    Long, Hui
    Wang, Li
    Lyu, Qifeng
    Ai, Ai
    Kuang, Yanping
    CLINICAL ENDOCRINOLOGY, 2018, 88 (03) : 442 - 452
  • [34] Resveratrol ameliorates mitochondrial biogenesis and reproductive outcomes in women with polycystic ovary syndrome undergoing assisted reproduction: a randomized, triple-blind, placebo-controlled clinical trial
    Ardehjani, Negar Ajabi
    Agha-Hosseini, Marzieh
    Nashtaei, Maryam Shabani
    Khodarahmian, Mahshad
    Shabani, Maryam
    Jabarpour, Masoome
    Fereidouni, Farzane
    Rastegar, Tayebeh
    Amidi, Fardin
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [35] Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial
    Huanhuan Zhang
    Yaping Chu
    Ping Zhou
    Xiaojin He
    Qianhua Xu
    Zhiguo Zhang
    Yunxia Cao
    Zhaolian Wei
    Reproductive Biology and Endocrinology, 14
  • [36] Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial
    Zhang, Huanhuan
    Chu, Yaping
    Zhou, Ping
    He, Xiaojin
    Xu, Qianhua
    Zhang, Zhiguo
    Cao, Yunxia
    Wei, Zhaolian
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2016, 14
  • [37] Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial
    Zhu, Xiuxian
    Ye, Hongjuan
    Ye, Jing
    Fu, Yonglun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (05)
  • [38] Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial
    Ye, Hongjuan
    Shi, Liya
    Quan, Xinxin
    Hou, Min
    Ma, Huilan
    Xue, Songguo
    Yu, Zhao
    Chen, Qiuju
    Sun, Lihua
    HUMAN FERTILITY, 2024, 27 (01)
  • [39] Comparison of DNA damage in granulosa cells of women undergoing controlled ovarian stimulation in in vitro fertilization protocols with the recombinant human follicle-stimulating hormones Corneumon®, Gonal-F®, Pergoveris® and Puregon®: a randomized trial
    Alcala-Sanchez, Ximena
    Cuapio-Padilla, Pedro
    Salazar-Lopez, Carlos
    Rodriguez, Ricardo
    Teteltitla, Mario
    Bahena, Ivan
    Betancourt, Miguel
    Casas, Eduardo
    Casillas, Fahiel
    Lopez, Alma
    Bonilla, Edmundo
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (05) : 2107 - 2114
  • [40] Comparison of DNA damage in granulosa cells of women undergoing controlled ovarian stimulation in in vitro fertilization protocols with the recombinant human follicle-stimulating hormones Corneumon®, Gonal-F®, Pergoveris® and Puregon®: a randomized trial
    Ximena Alcalá-Sánchez
    Pedro Cuapio-Padilla
    Carlos Salazar-López
    Ricardo Rodríguez
    Mario Teteltitla
    Iván Bahena
    Miguel Betancourt
    Eduardo Casas
    Fahiel Casillas
    Alma López
    Edmundo Bonilla
    Archives of Gynecology and Obstetrics, 2024, 309 : 2107 - 2114